| Literature DB >> 35801766 |
Giovanna Brandi1, Vittorio Stumpo2, Marco Gilone3, Lazar Tosic4, Johannes Sarnthein4, Victor E Staartjes4, Sophie Shih-Yüng Wang5, Bas Van Niftrik4, Luca Regli4, Emanuela Keller1,4, Carlo Serra4.
Abstract
INTRODUCTION: The integration of sex-related differences in neurosurgery is crucial for new, possible sex-specific, therapeutic approaches. In neurosurgical emergencies, such as traumatic brain injury and aneurysmal subarachnoid hemorrhage, these differences have been investigated. So far, little is known concerning the impact of sex on frequency of postoperative complications after elective craniotomy. This study investigates whether sex-related differences exist in frequency of postoperative complications in patients who underwent elective craniotomy for intracranial lesion.Entities:
Mesh:
Year: 2022 PMID: 35801766 PMCID: PMC9259102 DOI: 10.1097/MD.0000000000029267
Source DB: PubMed Journal: Medicine (Baltimore) ISSN: 0025-7974 Impact factor: 1.817
Grading of the postoperative complications based on the Clavien-Dindo-Classification.
|
| Any deviation from the normal postoperative course not requiring surgical, endoscopic or radiological intervention; this includes certain drugs (e.g., antiemetics, antipyretics, analgesics, diuretics and electrolytes), treatment with physiotherapy and wound infections that are opened at the bedside. |
|
| Complications requiring drug treatments other than those allowed for Grade I complications; these include blood transfusion and TPN. |
|
| Complications requiring surgical, endoscopic or radiological intervention. |
|
| Intervention not under general anesthetic. |
|
| Intervention under general anesthetic. |
|
| Life-threatening complications; these include CNS complications (e.g., brain hemorrhage, ischemic stroke, subarachnoid hemorrhage) which require intensive care, but excludes TIAs. |
|
| Single-organ dysfunction (including dialysis). |
|
| Multiorgan dysfunction. |
|
| Death of the patient. |
CNS = central nervous system, TIA = transient ischemic attacks, TPN = total parenteral nutrition.
Demographic data, clinical scores, and comorbidities of the study population
| Demographic | Overall | Male | Female |
|
|---|---|---|---|---|
| Sex | 664 | 325(48.9) | 339(51.1) | |
| Age | 56.56 (15.79) | 57.19 (15.44) | 55.95 (16.11) | .31 |
| BMI (kg/m2) | 25.86 (5.42) | 26.43 (4.83) | 25.33 (5.88) | <.05 |
| Smoking status | N = 658 | N = 323 | N = 335 | <.05 |
| No | 378 (57.4) | 165 (51.1) | 213 (63.6) | |
| Stopped | 132 (20.1) | 76 (23.5) | 56 (16.7) | |
| Yes | 148 (22.5) | 82 (25.4) | 66 (19.7) | |
| Alcohol abuse | 31/657 (4.7) | 21/323 (6.5) | 10/334 (3.0) | <.05 |
|
| ||||
| ASA class | N = 633 | N = 311 | N = 322 | <.05 |
| 1 | 43 (6.8) | 20 (6.4) | 23 (7.1) | |
| 2 | 350 (55.3) | 159 (51.1) | 191 (59.3) | |
| 3 | 224 (35.4) | 123 (39.5) | 101 (31.4) | |
| 4 | 16 (2.5) | 9 (3.0) | 7 (2.2) | |
| Risk class | N = 589 | N = 288 | N = 301 | .28 |
| 1 | 2 (0.3) | 1 (0.3) | 1 (0.3) | |
| 2 | 2 (0.3) | - | 2 (0.7) | |
| 3 | 135 (22.9) | 72 (25.0) | 63 (20.9) | |
| 4 | 450 (76.4) | 215 (74.7) | 235 (78.1) | |
| KPS at admission | 82.42 (15.61) | 82.89 (15.78) | 81.96 (15.46) | .31 |
|
| ||||
| Cardiac disorder | 166/623 (26.6) | 86/307 (28.0) | 80/316 (25.3) | .47 |
| Vascular disorder | 60/625 (9.6) | 29/309 (9.4) | 31/316 (9.8) | .89 |
| Hematologic disorder | 40/623 (6.4) | 15/308 (4.9) | 25/315 (7.9) | .13 |
| Respiratory disorder | 76/627 (12.1) | 39/309 (12.6) | 37/318 (11.6) | .72 |
| Hepatic disorder | 20/625 (3.2) | 13/306 (4.2) | 7/319 (2.2) | .17 |
| Renal disorder | 28/624 (4.5) | 17/306 (5.6) | 11/318 (3.5) | .24 |
| Metabolic disorder | 98/627 (15.6) | 49/308 (15.9) | 49/319 (15.4) | .91 |
| Allergic disorder | 155/624 (24.8) | 52/307 (16.9) | 103/317 (32.5) | <.001 |
| Neurological disorder | 216/621 (34.8) | 97/303 (32.0) | 119/318 (37.4) | .18 |
| Gastrointestinal disorder | 93/627 (14.8) | 45/309 (14.6) | 48/318 (15.1) | .91 |
| Skeletal disorder | 110/621 (17.7) | 52/308 (16.9) | 58/313 (18.5) | .60 |
| Muscular/rheumatic disorder | 31/621 (5.0) | 7/307 (2.3) | 24/314 (7.6) | <.01 |
| Ophthalmologic disorder | 99/611 (16.2) | 42/301 (14.0) | 57/310 (18.4) | .15 |
| Odontoiatric disorder | 123/606 (20.3) | 59/310 (19.0) | 64/296 (20.6) | .85 |
| Previous anesthesia problems | 23/565 (4.1) | 5/284 (1.8) | 18/281 (6.4) | <.01 |
Data are expressed as frequency with (percentage) or mean with (standard deviation), as indicated. A comparison between male and female was performed.
ASA = Class American Society of Anesthesiologist Classification, BMI = body mass index, KPS = Karnofsky performance status scale.
List of postoperative complications
| Complication | N (%) |
|---|---|
| None | 449 (67.2) |
| New neurological deficit (including transient) | 101 (15.1) |
| Seizures | 17 (2.5) |
| Delayed awakening | 21 (3.1) |
| Postoperative bleeding | 16 (2.4) |
| Metabolic | 12 (1.8) |
| Urinary tract infection | 7 (1.0) |
| Delirium | 6 (0.9) |
| Cerebral infarction | 6 (0.9) |
| Thromboembolic complication | 6 (0.9) |
| CSF fistula | 4 (0.6) |
| Intraoperative bleeding | 4 (0.6) |
| Others | 19 (2.8) |
Data are presented in frequency (percentage).
CSF = cerebrospinal fluid.
Frequency of complications at discharge and at 24 hours following intracranial surgery, and hospital length of stay in the study population
| Outcome | Overall (N/%) | Male (N/%) | Female (N/%) |
|
|---|---|---|---|---|
| Complication at discharge | 184/664 (27.7) | 87/325 (26.8) | 97/339 (28.6) | .61 |
| CDG | N = 663 | N = 324 | N = 339 | .70 |
| 0 | 448 (67.5) | 222 (68.6) | 226 (66.7) | |
| 1 | 128 (19.3) | 62 (19.1) | 66 (19.5) | |
| 2 | 60 (9.0) | 26 (8.0) | 34 (10.0) | |
| 3 | 4 (0.6) | 2 (0.6) | 2 (0.6) | |
| 3a | 3 (0.5) | 1 (0.3) | 2 (0.6) | |
| 3b | 12 (1.8) | 7 (2.2) | 5 (1.5) | |
| 4 | 1 (0.2) | 1 (0.3) | – | |
| 4a | 6 (0.9) | 3 (0.9) | 3 (0.9) | |
| 5 | 1 (0.2) | – | 1 (0.3) | |
| Complication at 24 h | 171/663 (25.8) | 84/325 (25.8) | 87/338 (25.7) | 1 |
| CDG | N = 663 | N = 325 | N = 338 | .97 |
| 0 | 490 (73.9) | 241 (74.2) | 249 (73.7) | |
| 1 | 138 (20.8) | 64 (19.7) | 74 (21.9) | |
| 2 | 31 (4.7) | 17 (5.2) | 14 (4.1) | |
| 3b | 4 (0.6) | 3 (0.9) | 1 (0.3) | |
| Hospital LOS (days) | 9.7 (±6.1) | 9.8 (±6.8) | 9.6 (±5.3) | .15 |
Data are expressed as frequency and percentage or mean and standard deviation.
CDC = Clavien-Dindo Classification, hospital LOS = hospital length of stay.
Histology stratification by gender
| Histology |
| |
|---|---|---|
|
| ||
|
| ||
| | 134/664 (20.2) | |
| Male | 86/325 (26.5) | <.001 |
| Female | 48/339 (14.2) | |
|
| ||
| | 47/664 (7.1) | |
| Male | 29/325 (12.0) | .09 |
| Female | 18/339 (5.3) | |
|
| ||
| | 7/664 (1.0) | |
| Male | 3/325 (0.9) | 1 |
| Female | 4/339 (1.2) | |
|
| ||
| | 35/664 (5.3) | |
| Male | 17/325 (5.2) | 1 |
| Female | 18/339 (5.3) | |
|
| ||
| | 147/664 (22.1) | |
| Male | 44/325 (13.5) | <.001 |
| Female | 103/339 (30.4) | |
|
| ||
| | 116/664 (17.5) | |
| Male | 31/325 (9.5) | <.001 |
| Female | 85/339 (25.1) | |
|
| ||
| | 31/664 (4.6) | |
| Male | 13/325 (4.0) | .46 |
| Female | 18/339 (5.3) | |
|
| ||
| | 63/664 (9.5) | |
| Male | 29/325 (8.9) | .70 |
| Female | 34/339 (9.7) | |
|
| ||
| | 110/664 (16.6) | |
| Male | 56/325 (17.2) | .68 |
| Female | 54/339 (15.9) | |
|
| ||
| | 16/664 (2.4) | |
| Male | 8/325 (2.5) | 1 |
| Female | 8/339 (2.4) | |
|
| ||
| | 22/664 (3.3) | |
| Male | 10/325 (3.1) | .83 |
| Female | 12/339 (3.5) | |
|
| ||
| | 83/664 (12.5) | |
| Male | 43/325 (13.2) | .63 |
| Female | 40/339 (11.8) |